Search results
Results from the WOW.Com Content Network
Gastroparesis and anorexia nervosa are two distinct illnesses, however, there is evidence of gastroparesis and gastrointestinal motility issues resulting from anorexia nervosa. Researchers suspect ...
Gastroparesis (gastro- from Ancient Greek γαστήρ – gaster, "stomach"; and -paresis, πάρεσις – "partial paralysis") is a medical disorder of ineffective neuromuscular contractions (peristalsis) of the stomach, resulting in food and liquid remaining in the stomach for a prolonged period of time.
A gastric emptying study is a nuclear medicine study which provides an assessment of the stomach's ability to empty.It may be used if there are complications after gastric surgery, for gastric reflux, or suspected gastroparesis amongst other indications. [1]
Velusetrag (INN, [1] USAN; previously known as TD-5108) is an experimental drug candidate for the treatment of gastric neuromuscular disorders including gastroparesis, and lower gastrointestinal motility disorders including chronic idiopathic constipation and irritable bowel syndrome. [2]
Drug makers are, however, required to disclose potential dangers—and disclosure is at the heart of patient lawsuits, with users claiming they were not adequately warned about gastroparesis or ...
Gastroparesis is another common misdiagnosis. [2] Like rumination syndrome, patients with gastroparesis often bring up food following the ingestion of a meal. Unlike rumination, gastroparesis causes vomiting (in contrast to regurgitation) of food, which is not being digested further, from the stomach. This vomiting occurs several hours after a ...
In one long-term investigation, a high body mass index was an independent predictor of the emergence of functional dyspepsia. [ 14 ] Since the brain and gut communicate through the hypothalamic-pituitary-adrenal axis and the enteric nerve system, psychological comorbidity plays a significant influence in the development of functional dyspepsia ...
Deudomperidone (developmental code name CIN-102; also known as deuterated domperidone) is a dopamine antagonist medication which is under development in the United States for the treatment of gastroparesis. [1] [2] [3] It acts as a selective dopamine D 2 and D 3 receptor antagonist and has peripheral selectivity.